EcoDrugPlus

Ensembl ID : ENSEEEG00000020764
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSEEEG00000021562
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSEEEG00000012167
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSEEEG00000018717
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSEEEG00000021563
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSEEEG00000021564
Gene Symbol: -
Cross references: -
108 Possible Orthologues:

Ensembl ID : ENSEEEG00000019337
Gene Symbol: -
Cross references: -
156 Possible Orthologues:

Ensembl ID : ENSEEEG00000019457
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSEEEG00000019459
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSEEEG00000021565
Gene Symbol: -
Cross references: -
112 Possible Orthologues:

Ensembl ID : ENSEEEG00000019387
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSEEEG00000012085
Gene Symbol: -
Cross references: -
163 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).